Navidea Biopharmaceuticals Sells Preferred Shares Worth $1.1 Million

Moomoo 24/7 ·  05/23 17:42
Navidea Biopharmaceuticals (NAVB) said late Monday it sold preferred shares totaling $1.1 million to investors, with proceeds slated to advance its NAV3-32 and NAV3-33 clinical trials toward completion. The company's shares gained more than 16% in premarket activity Tuesday.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write first comment